Alendronate

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

FOSAMAX, FOSAVANCE – Merck Frosst Canada Ltd. (NOC Search)

Patents:

1264326: NOVOPHARM
1320727: NOVOPHARM
2018477: COBALT, NOVOPHARM
2149052: APOTEX, NOVOPHARM, COBALT
2221417: APOTEX, NOVOPHARM, COBALT
2294595: COBALT, NOVOPHARM, APOTEX

APOTEX

PM(NOC) – A-499-07 – A-500-07 (2008 FCA 371) – T-1053-03 – T-1106-03 – T-884-03 (2007 FC 1035, 2007 FC 312)
Section 8 – T-1144-05 (2008 FC 1185, 2012 FC 1235, 2012 FC 1418)
Appeal – A-495-12 – A-496-12 – A-568-12 – A-571-08 (2009 FCA 187) – A-580-08

COBALT

PM(NOC) – T-541-04

NOVOPHARM

PM(NOC) – T-1053-06 – T-160-04 – T-1627-03 – T-1737-02 – T-1738-02 – T-44-03

Return to the Patented Medicine Litigation page.

Canadian Intellectual Property